EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

NT-proBNP Cut-off Values for Risk Stratification in Acute MI and Comparison with Other Risk Assessment Scores

Shirley Siang Ning Tan, Keng Tat Koh, Alan Yean Yip Fong, Mohammad Adam bin Bujang, Lee Len Tiong, Yee Ling Cham, Kian Hui Ho, Chen Ting Tan, Chee Sin Khaw, Nor Hanim Mohd Amin, Yen Yee Oon, Asri Said und 7 weitere

Journal of Asian Pacific Society of Cardiology · 2022

DOI: 10.15420/japsc.2021.14 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Asian Pacific Society of Cardiology, 2022. Verfasst von Shirley Siang Ning Tan und 18 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

N-terminal pro-brain natriuretic peptide (NT-proBNP) provides prognostic information regarding the risk of death, acute heart failure and the development of AF in patients with acute coronary syndrome. While there are established cut-off values for the association between clinical risk assessment scores and in-hospital mortality, there is no clear cut-off value for NT-proBNP to guide risk stratification in patients with acute MI (AMI). Our study sought to evaluate the cut-off values of NT-proBNP in all-cause mortality post AMI and to compare with other available risk assessment scores.

Methods

We conducted a multi-centre, prospective, observational study involving 411 patients admitted for AMI. Plasma NT-proBNP was assessed within 24 hours of admission.

Results

One-year all-cause mortality occurred in 31 (7.6%) of 411 patients. NT-proBNP ≥404 pg/ml had an area under the curve of 0.66 (95% CI [0.54–0.77]; p=0.004) to predict all-cause mortality at 1 year (sensitivity: 80.6%; specificity: 36.9%; positive predictive value: 9.47%; negative predictive value: 95.89%). Using the Youden index, an NT-proBNP level ≥1,995 pg/ml was an independent predictor of all-cause mortality at 1 year (adjusted HR 2.6; 95% CI [1.3–5.5]; p=0.010), regardless of cardiovascular disease risk factors or revascularisation status. There were no significant differences among the predictive values of NT-proBNP, Thrombolysis in MI risk score, Global Registry of Acute Coronary Events risk score and left ventricular ejection fraction in predicting all-cause mortality at 1 year (p>0.05).

Conclusion

NT-proBNP level ≥1,995 pg/ml measured within 24 hours of admission for AMI was associated with higher all-cause mortality at 1 year. Randomised controlled trials are needed to further validate the usefulness of NT-proBNP for risk stratification in patients with AMI.

Zitieren

APA

Tan, S. S. N., Koh, K. T., Fong, A. Y. Y., Bujang, M. A. B., Tiong, L. L., Cham, Y. L., Ho, K. H., Tan, C. T., Khaw, C. S., Amin, N. H. M., Oon, Y. Y., Said, A., Lau, K. T., Yong, K. Y., Pang, D. C. L., Bhavnani, C. D., Wong, I. T., Shu, F. E. P., & Ong, T. K. (2022). NT-proBNP Cut-off Values for Risk Stratification in Acute MI and Comparison with Other Risk Assessment Scores. Journal of Asian Pacific Society of Cardiology. https://doi.org/10.15420/japsc.2021.14

Vancouver

Tan SSN, Koh KT, Fong AYY, Bujang MAB, Tiong LL, Cham YL, et al. NT-proBNP Cut-off Values for Risk Stratification in Acute MI and Comparison with Other Risk Assessment Scores. Journal of Asian Pacific Society of Cardiology. 2022. doi:10.15420/japsc.2021.14

BibTeX
@article{Tan2022,
  author = {Tan, Shirley Siang Ning and Koh, Keng Tat and Fong, Alan Yean Yip and Bujang, Mohammad Adam bin and Tiong, Lee Len and Cham, Yee Ling and Ho, Kian Hui and Tan, Chen Ting and Khaw, Chee Sin and Amin, Nor Hanim Mohd and Oon, Yen Yee and Said, Asri and Lau, Kent Ter and Yong, Kar Ying and Pang, Daniel Cheng Lee and Bhavnani, Chandan Deepak and Wong, Ing Tien and Shu, Francis Eng Pbeng and Ong, Tiong Kiam},
  title = {NT-proBNP Cut-off Values for Risk Stratification in Acute MI and Comparison with Other Risk Assessment Scores},
  journal = {Journal of Asian Pacific Society of Cardiology},
  year = {2022},
  doi = {10.15420/japsc.2021.14}
}
Kostenlos starten →